IMRIS and Varian developing cancer treatment system with potential to improve accuracy and effectiveness<br />
<br />
ATLANTA – IMRIS Inc. (NASDAQ: IMRS; TSX: IM) and Varian Medical Systems (NYSE: VAR) today announced that data presented here earlier this week at the American Society for Radiation Oncology (ASTRO) Annual Meeting demonstrates the potential to direct state-of-the-art radiation treatments using diagnostic-quality MR images at each treatment session.<br />
<br />
In a ...This story is related to the following:Vision SystemsRadiotherapy Systems | Diagnostic Imaging Equipment | Medical Diagnostic Equipment |